Background: Sexually transmitted infections are a major public health problem especially with the advent of HIV/AIDS. This study was conducted to determine the prevalence of Syphilis among HIV seropositive persons. The study population was seropositive persons accessing antiretroviral therapy (ART) at the Federal Medical Center Keffi. Methodology: Venous blood (5ml) was collected from each of the 200 consenting participants between February and August 2010. Their syphilis serostatus was determined using Rapid Plasma Reagin test and confirmed by an immunochromatographic rapid syphilis test kit. The CD4 count of the positive sample was also determined. Results: Of the 200 persons screened, 56 were males and 144 were females. The prevalence of Treponema pallidum in this study population was 0.5% (1/200). The HIVsyphilis positive was a married man aged 35 years and with a CD4 cell count of ≥ 200 cells/uL. Conclusion: This study reported a very low prevalence of syphilis among HIV positive persons. It is recommended that the sexual partner(s) of the study index case should be traced and also treated to prevent reinfection and/or continued spread of the infection. Despite the low prevalence in this study, syphilis screening among those with HIV should be advocated routinely to avoid the complications associated with the dual infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.